Adição na publicação
#15.35
10/05/2021
RPI 2648
Application data
Number
112019001206Type
Filing
Publication
PCT
US2017042855 The application was abandoned: examination was not requested within the 36 months following the 07/19/2017 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 10/05/2021. We update with every new RPI gazette, published weekly.
Applicants
AERPIO THERAPEUTICS INC.
US
Inventors
K. P. (pessoa física)
US
M. F. (pessoa física)
US
IPC Classification
Priority claims
US
62/364,381 · 07/20/2016
US
62/377,072 · 08/19/2016
Abstract
A revelação proporciona composições e métodos para o tratamento de condições oculares associadas a angiogênese compreendendo a administração de um anticorpo que visa um inibidor da tirosina fosfatase num indivíduo.
Publications in the Brazilian Industrial Property Gazette (RPI).
#15.35
10/05/2021
RPI 2648
#11.1.1
03/09/2021
RPI 2618
#11.1
12/22/2020
RPI 2607
#1.3
06/25/2019
RPI 2529
#1.1
01/29/2019
RPI 2508
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.